Expression of MAL2, an integral protein component of the machinery for basolateral-to-apical transcytosis, in human epithelia

被引:25
作者
Marazuela, M
Acevedo, A
García-López, MA
Adrados, M
De Marco, MC
Alonso, MA [1 ]
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias, E-28049 Madrid, Spain
[2] Hosp Princesa, Dept Endocrinol, Madrid, Spain
[3] Hosp Princesa, Dept Pathol, Madrid, Spain
[4] CSIC, Madrid, Spain
关键词
epithelial cell; sorting machinery; transcytosis; MAL protein family; rafts; carcinoma;
D O I
10.1177/002215540405200212
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
MAL2, an integral membrane protein of the MAL family, is an essential component of the machinery necessary for the indirect transcytotic route of apical transport in human hepatoma HepG2 cells. To characterize the range of human epithelia that use MAL2-mediated pathways of transport, we carried out an immunohistochemical survey of normal tissues using a monoclonal antibody specific to the MAL2 protein. MAL2 expression was detected in specific types of normal epithelial cells throughout the respiratory system, the gastrointestinal and genitourinary tracts, in exocrine and endocrine glands, and in hepatocytes. Many different types of specialized secretory cells, either organized in discrete clusters (e.g., endocrine cells in the pancreas) or in endocrine glands (e.g., prostate), were also positive for MAL2. In addition to epithelial cells, peripheral neurons, mast cells, KEY WORDS and dendritic cells were found to express MAL2. For comparison with normal epithelial tissue, different types of renal carcinoma were also analyzed, revealing alterations in MAL2 sorting machinery expression/distribution dependent on the particular histological type of the tumor. Our results allow the prediction of the existence of MAL2-based trafficking pathways in specific MAL protein family cell types and suggest applications of the anti-MAL2 antibody for the characterization of rafts neoplastic tissue.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 13 条
[1]   VIP17/MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells [J].
Cheong, KH ;
Zacchetti, D ;
Schneeberger, EE ;
Simons, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6241-6248
[2]   MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells [J].
de Marco, MC ;
Martín-Belmonte, F ;
Kremer, L ;
Albar, JP ;
Correas, I ;
Vaerman, JP ;
Marazuela, M ;
Byrne, JA ;
Alonso, MA .
JOURNAL OF CELL BIOLOGY, 2002, 159 (01) :37-44
[3]  
de Marco MD, 2001, J BIOL CHEM, V276, P23009
[4]   Expression of MAL, an integral protein component of the machinery for raft-mediated apical transport, in human epithelia [J].
Marazuela, M ;
Acevedo, A ;
Adrados, M ;
García-López, MA ;
Alonso, MA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (05) :665-673
[5]  
MARAZUELA M, 1995, CLIN EXP IMMUNOL, V102, P328
[6]   MAL mediates apical transport of secretory proteins in polarized epithelial Madin-Darby canine kidney cells [J].
Martín-Belmonte, F ;
Arvan, P ;
Alonso, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49337-49342
[7]   Expression of the MAL gene in the thyroid:: the MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles [J].
Martín-Belmonte, F ;
Kremer, L ;
Albar, JP ;
Marazuela, M ;
Alonso, MA .
ENDOCRINOLOGY, 1998, 139 (04) :2077-2084
[8]   The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and Fischer rat thyroid cell lines [J].
Martín-Belmonte, F ;
Puertollano, R ;
Millán, J ;
Alonso, MA .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (06) :2033-2045
[9]   MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway [J].
Mimori, K ;
Shiraishi, T ;
Mashino, K ;
Sonoda, H ;
Yamashita, K ;
Yoshinaga, K ;
Masuda, T ;
Utsunomiya, T ;
Alonso, MA ;
Inoue, H ;
Mori, M .
ONCOGENE, 2003, 22 (22) :3463-3471
[10]  
Murphy WM, 1994, ATLAS TUMOR PATHOL, P92